Swiss drug developer Basilea Pharmaceutica has entered into an exclusive license agreement with Venatorx Pharmaceuticals, to ...

Flagship Pioneering has appointed Ajit Singh as chief executive (CEO)-partner of Flagship and the new CEO of Harbinger Health ...

A first-of-its-kind study from UK pharm major AstraZeneca and Macmillan Cancer Support into the barriers around access to the ...

Schrödinger (Nasdaq: SDGR) has halted the clinical development of its oral drug SGR-2921 following the occurrence of two ...

US President Donald Trump issued an executive order on August 13 2025 instructing the Department of Health and Human Services ...

With help from artificial intelligence, Massachusetts Institute of Technology (MIT) researchers have designed novel ...

Eli Lilly (NYSE: LLY) has entered into a collaboration with Boston-based Superluminal Medicines to develop small-molecule ...

US pharma major Eli Lilly is raising the list price for its obesity drug Mounjaro (tirzepatide) in the UK by as much as 170%, as the pharma industry comes under pressure from US President Donald Trump ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for AstraZeneca’s ...

Pilatus Biosciences, a US biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and ...

Danish clinical-stage techbio, Evaxion, which is specializing in developing AI-Immunology powered vaccines, today provided a ...

US biotech Response Pharmaceuticals (Nasdaq: RSPN) has unveiled top-line Phase II results for its experimental obesity ...